SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-10-002633
Filing Date
2010-07-14
Accepted
2010-07-14 17:06:14
Documents
7
Period of Report
2010-04-30

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. FORM 10-K peregrine_10k-043010.htm 10-K 2018021
2 RESTRICTED STOCK ISSUANCE AGREEMENT peregrine_10k-ex0415.htm EX-4.15 62960
3 SUBSIDIARIES peregrine_10k-ex2100.htm EX-21 3679
4 CONSENT peregrine_10k-ex2301.htm EX-23.1 3152
5 CERTIFICATION peregrine_10k-ex3101.htm EX-31.1 12112
6 CERTIFICATION peregrine_10k-ex3102.htm EX-31.2 11847
7 CERTIFICATION peregrine_10k-ex3200.htm EX-32 10584
  Complete submission text file 0001019687-10-002633.txt   2123542
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-32839 | Film No.: 10952678
SIC: 2835 In Vitro & In Vivo Diagnostic Substances